Compare Cassava Sciences Inc (FLNA) vs United Microelectronics Corp (UMC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs United Microelectronics Corp — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while United Microelectronics Corp trades at $22.28 (market cap $65.12B). The key difference: United Microelectronics Corp is far larger — about 1225.4× Cassava Sciences Inc's market cap, and United Microelectronics Corp pays a 1.65% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | UMC | |
|---|---|---|
Market Cap | $53.14M | $65.12B |
Sector | Health | Technology |
52-Week High | $4.64 | $28.02 |
52-Week Low | $1.09 | $6.58 |
Enterprise Value | -$33.43M | $62.70B |
Dividend Yield | — | 1.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
UMC trades at $22.26, down 6.63% over the past day, with a bullish technical signal driven by moving averages and positive momentum indicators. The company reported Q1 2026 EPS of $0.20, beating expectations, and maintains strong profitability with a 20.25% net income margin. Recent news highlights mass production milestones in silicon photonics and 14nm eHV FinFET platform advancements, supporting growth in AI and automotive demand.
Outlook remains positive with solid revenue growth and margin stability, though valuation ratios like P/E of 40.46 suggest premium pricing. Risks include competitive pressures and cyclical semiconductor demand. Analyst consensus is mixed with 26.7% buy ratings, indicating cautious optimism amid high expectations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About United Microelectronics Corp
Founded in 1980, United Microelectronics is the world's third-largest dedicated chip foundry, with 7% market share in 2021, according to Gartner, after TSMC and GlobalFoundries. UMC's headquarters are in Hsinchu, Taiwan, and it operates 12 fabs in Taiwan, Mainland China, Japan and Singapore, with additional sales offices in Europe, the U.S. and South Korea. UMC features a diverse customer base including Texas Instruments, MediaTek, Qualcomm, Broadcom, Xilinx and Realtek, supplying a wide range of products applied in communications, display, memory, automotive and more. UMC employs about 20,000 people.
Read more on UMC →
